Print

Immunotherapy drug Keytruda received FDA approval and showed benefit for treatment of colorectal cancer

https://www.facingourrisk.org/XRAY/keytruda-effective-in-treating-colorectal-cancer
Full article: https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-pembrolizumab-first-line-treatment-msi-hdmmr-colorectal-cancer

In June 2020, the FDA approved Keytruda (pembrolizumab) as an initial therapy for advanced colorectal cancer. This approval was based on the results from the KEYNOTE-177 study. In this study, Keytruda was more successful than chemotherapy in delaying progression of certain types of colorectal cancers. (11/25/20)

Questions To Ask Your Health Care Provider

Open Clinical Trials

The following studies enroll people with advanced colorectal cancer:

Several other clinical trials for patients with colorectal cancer can be found here.

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.